Ampio Pharmaceuticals (AMPE) Accused of Making Misleading Statements about its Drug Candidate Ampion One of Ampio Pharmaceuticals’s lead product candidates is Ampion, a biologic intra-articular injection which is being studied

Robbins LLP Is Investigating the Officers and Directors of Super Micro Computer, Inc. (SMCI) on Behalf of Shareholders September 13, 2018 (San Diego, CA & San Jose, CA) – Shareholder

Fanhua Inc. (FANH) Accused of Engaging in Irregular Accounting According to the complaint, Fanhua Inc.(FANH) boasted that its first quarter 2018 financial results beat expectations. Fanhua further predicted that the

Qurate Retail Group, Inc. (QRTEA) Accused of Misstating True Reasons for Sales Growth According to the recently filed class action complaint, Qurate Retail Group, Inc. (QRTEA) claimed that its broad-based

Cronos Group, Inc. Accused of Deceiving Investors About the Size of Its Distribution Agreements According to the complaint, on August 21, 2018, Cronos Group, Inc. announced that it had signed

Tableau Accused of Downplaying Competitive Threats According to a recently filed complaint, Tableau Software, Inc. (DATA) assured the public in press releases, presentations, and conference calls that the company would

Robbins LLP Is Investigating the Officers and Directors of Sea Limited (SE) on Behalf of Shareholders September 5, 2018 (San Diego, CA & Singapore) – Shareholder rights law firm Robbins

Skechers U.S.A., Inc. (SKX) Accused of Unjustifiably Inflating the Company’s Sales Growth According to the recently filed class action complaint, Skechers U.S.A., Inc. (SKX) officials schemed to artificially inflate the

CV Sciences, Inc. Accused of Omitting Rejection of Its Patent in Its Reports According to the recently filed class action complaint, CV Sciences, Inc. (OTC: CVSI) touted that CVSI-007 had